Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.248 EUR | 0.00% | +0.48% | -3.11% |
03-14 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
03-11 | Abionyx: reduced net loss in 2023 | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.11% | 43.75M | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Cerenis Therapeutics Holding SA Provides Revenue Guidance for the First Half of 2019